76
Participants
Start Date
August 31, 2010
Primary Completion Date
November 30, 2018
Study Completion Date
June 30, 2019
Teplizumab
intravenous infusions
Placebo infusion
Placebo for Teplizumab
Columbia University, New York
University of Pittsburgh, Pittsburgh
University of Florida, Gainesville
University of Miami, Miami
University of South Florida, Tampa
Vanderbilt University, Nashville
Indiana University, Indianapolis
University of Minnesota, Minneapolis
The Children's Mercy Hospital, Kansas City
Baylor College of Medicine, Houston
Barbara Davis Center for Childhood Diabetes/ University of Colorado, Denver
University of California in San Francisco, San Francisco
University of California-San Francisco, San Francisco
Stanford University, Stanford
Benaroya Research Institute, Seattle
Yale University School of Medicine, New Haven
University of Texas, Dallas
The Hospital for Sick Children, Toronto
Forschergruppe Diabetes, Munich
Collaborators (1)
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
National Center for Research Resources (NCRR)
NIH
Juvenile Diabetes Research Foundation
OTHER
American Diabetes Association
OTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH